Palantir Technologies Inc. is trading 4.4% down today at €132.06 after a UK parliamentary committee issued a critical report regarding the company's major contract with the National Health Service (NHS).
- A Science, Innovation and Technology Committee report published today called Britain's reliance on Palantir an "unacceptable point of weakness".
- The committee urged the government to consider exercising a 2027 break clause in the seven-year, £330 million NHS Federated Data Platform contract.
- The report has raised concerns about vendor lock-in and data sovereignty, putting a key government contract for Palantir under political pressure.